Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | NME4 | O00746 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.41 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.41 |
| ▸ | HTR3A | P46098 | 1/20 | 0.41 |
| ▸ | GCDH | Q92947 | 1/20 | 0.41 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.41 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21786995 | 0.84 | HTT (0.43) | CA1CA2TDP1NME4ADORA3 | |
| SCHEMBL21786993 | 0.83 | CA1 (0.46) | BACE1CA1CA2TDP1MAPK1 | |
| SCHEMBL13523477 | 0.78 | CA1 (0.46) | CA1CA2THRBALDH1A1TP53 | |
| SCHEMBL24346426 | 0.77 | HTT (0.46) | CA1CA2TDP1NME4ADORA3 | |
| Hydrochloric Acid SCHEMBL20771828 | 0.77 | PLK1 (0.54) | CA1CA2TDP1CA9TAAR1 | |
| SCHEMBL22108057 | 0.75 | CA1 (0.43) | CA1CA2TDP1THRBMAPK1 | |
| SCHEMBL8609862 | 0.74 | TRPV1 (0.50) | THRBKDM4E | |
| SCHEMBL26324657 | 0.74 | HPGD (0.49) | CA1CA2TDP1NME4ADORA3 | |
| SCHEMBL17430663 | 0.73 | POLB (0.38) | SIRT5THRBMAPK1MAPTKDM4E | |
| SCHEMBL23734235 | 0.73 | MAPT (0.45) | BACE1TDP1MAPK1TAAR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230374582-A1 | METHOD COMPRISING LIGHT-EMITTING MARKER | SUMITOMO CHEMICAL CO., LTD. (JP) | 2023-11-23 | — | — | US | disclosed |
| WO-2022079005-A1 | METHOD COMPRISING LIGHT EMITTING MARKER | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2022-04-21 | — | — | WO | disclosed |
| US-20210139976-A1 | NUCLEOTIDE ANALOGUES AND USE THEREOF FOR NUCLEIC ACID SEQUENCING AND ANALYSIS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2021-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139976-A1 | NUCLEOTIDE ANALOGUES AND USE THEREOF FOR NUCLEIC ACID SEQUENCING AND ANALYSIS | NUDT1, NT5C3B, RNGTT | BACE1 4717/4885CA1 4780/4885CA2 4691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.